Roles of ERK1/2 and AKT signals in regulating erlotinib or emodin-induced cytotoxicity and suppression of Rad51 and ERCC1 expression in human lung cancer cells
碩士 === 國立嘉義大學 === 生化科技學系研究所 === 98 === Lung cancer is one of the most common malignant tumor in the world. Erlotinib (Tarceva®) is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in the treatment of human non-small cell lung cancer (NSCLC). Emodin, acting like a tyrosin...
Main Authors: | Ying-Jhen Su, 蘇英禎 |
---|---|
Other Authors: | Yun-Wei Lin |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/71912210753146462780 |
Similar Items
-
Roles of ERK1/2 and AKT signals mediated Rad51 and ERCC1 downregulation overcomes Gemcitabine and Capecitabine drugs resistance in non-small cell lung cancer
by: Min-Shao Tsai, et al.
Published: (2011) -
Emodin affects ERCC1 expression in breast cancer cells
by: Fu Jian-min, et al.
Published: (2012-09-01) -
Homologous pairing activities of two rice RAD51 proteins, RAD51A1 and RAD51A2.
by: Yuichi Morozumi, et al.
Published: (2013-01-01) -
Promotion of RAD51-Mediated Homologous DNA Pairing by the RAD51AP1-UAF1 Complex
by: Fengshan Liang, et al.
Published: (2016-06-01) -
The mechanism of SWI5-SFR1 and RAD51AP1 stimulating RAD51-mediated recombination
by: Chia-Yu Liao, et al.
Published: (2013)